Skip to content
Clinical Trials – home

Universita Degli Studi Di Messina

Verified siteinfo

Italy Via Consolare Valeria 1, 98125 Messina, Italy

  • 5 trials recruiting
  • Asthma · Coeliac disease · Glycogen storage disease type II
  • Adults and children

About Specializations

Universita Degli Studi Di Messina in Messina, Italy specialises in clinical trials of conditions such as Asthma, Coeliac disease, Glycogen storage disease type II, Type 1 diabetes mellitus, and other specialisations. This site conducts important research.

Main research areas of the site

Respiratory Tract Diseases

Clinical research at Universita Degli Studi Di Messina includes studies in asthma and other respiratory tract diseases, with attention to both moderate-to-severe controlled asthma and severe eosinophilic asthma. The trials are designed to assess treatment performance and long-term safety while exploring new options that may improve symptom control.

  • Severe asthma with an eosinophilic phenotype
  • Moderate to severe controlled asthma
  • Evaluation of new therapies for asthma management
  • Long-term safety and effectiveness of respiratory treatments

This area reflects a strong focus on improving care for chronic airway disease through better disease control and safer treatment strategies.

Digestive System Diseases

The site is also active in digestive system diseases, including research on pediatric bowel cleansing for colonoscopy preparation in children and teenagers with colonic disease. These studies aim to improve diagnostic readiness and support more effective gastrointestinal care in younger patients.

  • Colonic disease
  • Improving bowel preparation before colonoscopy
  • Testing the effectiveness of cleansing approaches in pediatric care
  • Supporting better diagnostic outcomes in gastrointestinal research

This line of research highlights practical advances in how digestive conditions are assessed and managed, especially in pediatric populations.

Nutritional and Metabolic Diseases

In nutritional and metabolic diseases, clinical trials at the DAI Materno Infantile are focused on type 1 diabetes and late-onset Pompe disease. The studies are evaluating whether new add-on treatments can help preserve insulin-producing cell function or improve lung function in patients already receiving standard care.

  • Diabetes Mellitus, Type 1
  • Late-onset Pompe disease
  • Preservation of beta-cell function in new-onset diabetes
  • Assessing added treatment benefit in metabolic disease

This research aims to expand treatment possibilities for complex chronic disorders by testing therapies that may improve long-term disease control and organ function.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Via Consolare Valeria 198125 MessinaItaly
Recruiting now
5 trials
Conditions studied
5
Partner status
Verified site

More sites in MessinaItaly

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

7 clinical trials

Coeliac disease

Recruiting

Study on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Methyl (E,6S)-7-[[1-[2-(2-Ethylbutylamino)-2-Oxoethyl]-2-Oxopyridin-3-Yl]Amino]-6-[(3-Methylimidazole-4-Carbonyl)Amino]-7-Oxohept-2-Enoate
  • Sponsor:Dr. Falk Pharma GmbH

A Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes

Registered drug
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years
  • Substances:Baricitinib
  • Sponsor:Eli Lilly & Co.

Phase 3 Study of Oral Orforglipron vs Weekly Dulaglutide in Children and Adolescents (10‑<18 years) with Type 2 Diabetes

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Dulaglutide
  • Sponsor:Eli Lilly & Co.

A Study of S-606001 Added to Enzyme Replacement Therapy for Patients with Late-Onset Pompe Disease

Investigational
Countries:ItalyItaly
  • Participants:18–64 years
  • Sponsor:Shionogi B.V.
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Ascorbic Acid
  • Sponsor:Norgine Limited

Asthma

Not recruiting

Study on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:Chiesi Farmaceutici S.p.A.

Asthma

Not recruiting

Study on Long-Term Safety of Depemokimab for Adults and Adolescents with Severe Eosinophilic Asthma

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.